Caidya

Other Healthcare Services · Raleigh, NC · Founded 2004 · Privately Held (backing)

Operator of a bio-pharmaceutical-based contract research organization (CRO) designed to facilitate the globalization of drugs. Caidya is based in Raleigh, NC and was founded in 2004. It was valued at $1 billion at its later-stage round in Jul 2021, the last priced event on record. It has raised $375 million across 1 recorded round; the latest was a $100 million Series C in Dec 2020.

PMV mark · valuation
$1.0B
Oct 2026
Priced at
its later-stage round
Jul 2021
Total raised
$375.1M
Last round
Later Stage VC (Series C)
Dec 2020

Who backs Caidya?

22 investors
InvestorType
Sequoia CapitalVenture capital
Hongshan Capital GroupOther
Fidelity Management & Research CompanyAsset manager
Qiming Venture PartnersVenture capital
Legend StarVenture capital
Hatteras Venture PartnersVenture capital
Rock Springs CapitalHedge fund
Harbert Growth PartnersGrowth equity
Rubicon FoundersPE / buyout
Lilly Asia VenturesVenture capital
+ 12 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Caidya investors

22 investors are on record for Caidya, including Sequoia Capital, Hongshan Capital Group, Fidelity Management & Research Company and Qiming Venture Partners. By type, the record holds 5 venture capital firms and 3 hedge funds. The Series C in Dec 2020 drew 4 investors.

Free account
More of Caidya with a free account
  • ·The complete investor list: 22 names
  • ·Watch Caidya: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 22 firms already write checks for companies like Caidya in other healthcare services. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View